Developing T-Cell Adaptive Vaccines against viral and bacterial infectious diseases, using purely synthetic non-biological components that prime immune cells to destroy pathogen-infected cells

Gylden Vaccines

We work on addressing some of the world’s most immediate health threats (including viral diseases such as Dengue Fever, COVID-19, Zika, Ebola and pandemic Influenza, as well as serious intracellular bacterial infections) and have a growing pipeline of vaccine candidates.